Discover Great Companies Discover Great Clients
Popularity  52.7万   |   Followers  1823   |   Likes  8   |   Feedback  1595 Claim this company

One of China's Top 20 Listed Pharmaceutical Companies

No.3 Shijiazhuang City Popularity Ranking No.1 Development Zone No.5 Hebei Prov No.1 Chemical Raw Materials No.1 Health Products No.1 Hua Gong / Chemistry No.1 Yin Fa Jing Ji No.1 Yu Fang Bao Jian No.1 Jian Kang Chan Industries No.1 Wellness No.1 Health Technology No.1 Health No.1 Health Management No.1 Zhong Pharmaceuticals No.1 Wen Lv / Culture Tourism 企业技术中心 国家科技进步奖 省部级科技进步奖 博士后工作站 国家技术发明奖 国家高新技术企业
More

Company Overview

  • Nature: Listed Company Size: Over 10,000 employee Founded: 25年
  • Industry: Pharmaceuticals/Bioengineering 、 FMCG (Food/Beverages/Cosmetics)
  • Full name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.。

Development Stage

  • Stage: IPO上市, 主板, 深交所。
  • Ranking: Ranked #3 in Shijiazhuang City by popularity Ranked #1 in Shijiazhuang Chemical Raw Materials Company by popularity Ranked #1 in Shijiazhuang Health Products Company by popularity Ranked #1 in Shijiazhuang Hua Gong / Chemistry Company by popularity Ranked #1 in Shijiazhuang Yin Fa Jing Ji Company by popularity
  • Honors: 2023中国企业慈善公益500强 2023中国高新技术企业慈善公益500强 企业技术中心 国家科技进步奖 According to algorithm
  • News: 2026-10-20:以岭药业:LB220-D08缓释片药物临床试验申请获批。
  • Salary: 74.2% of positions earn 6-15K, In 2026 vs last yeargrew by 15%.。Master's salary: ¥23.7K, Doctorate salary: ¥39.5K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 24.3%, "Computer/Network/Technology": 5.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 3.7%。
  • Recruiting: In 2026 vs 2025grew by 53%. Demand for highly educated talent: Master's: 86, Doctorate: 13.
  • Requirement: Education: 大专 leads with 60.9%. Experience: 1-3年 leads with 50.7%.
  • Region: Distributed across 100 regions, 石家庄: 21.4%, 北京: 8.4%, 上海: 4.6%, 衡水: 3.4%.

About the Company

[Summary] One of China's Top 20 Listed Pharmaceutical Companies

Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded on June 16, 1992 (stock code: 002603). With the corporate mission of "Inheriting and Innovating for the Benefit of Humanity," the development goal of "Technological Health for Tomorrow," and the management philosophy of "Developing for Employees, Contributing to Society, and Creating Value for Shareholders," the company consistently adheres to an innovation-driven development strategy led by technology and guided by the market. It systematically established the theoretical framework of Luobing (Collateral Disease) Theory, pioneered the integrated operating model of "Theory - Clinical Practice - New Drugs - Industry - Education," and formed an industrial development cluster spanning "from medicine to healthcare to wellness." The "TCM Collateral Disease Diagnosis and Treatment Method" has been inscribed in the national intangible cultural heritage list, and "Luobingxue (Collateral Disease Theory)" has become a university textbook, taught in over 40 universities nationwide. The company has successively undertaken more than 60 national and provincial/ministerial research projects, including the National 973 Program, the National 863 Program, the National Natural Science Foundation of China, and the National Key R&D Program. The company has developed over 10 patented new drugs, including Tongxinluo Capsules for treating coronary heart disease and cerebral infarction, Shensong Yangxin Capsules for treating arrhythmias, Qili Qiangxin Capsules for chronic heart failure, Lianhua Qingwen Capsules for colds and influenza, and Bazi Bushen Capsules for tonifying kidney essence and anti-aging. It has obtained over 800 patents and has been honored with six national awards, including the First Prize and Second Prize of the National Science and Technology Progress Award. The company has established five production and R&D bases in Hebei and Beijing, built over 60 raw material medicinal herb bases nationwide, and its production workshops have passed international certifications from the United States, the European Union, Canada, New Zealand, and other countries and regions, establishing a comprehensive quality control system in line with international standards. Lianhua Qingwen is marketed in over 30 countries. Recognized as one of China's Top 10 Traditional Chinese Medicine Enterprises, one of China's Top 20 Listed Pharmaceutical Companies, one of the Top 500 Listed Companies by Market Value in China, and one of China's Top 100 Most Valuable Brands, the company was also honored by the CPC Central Committee with the title of "National Advanced Primary Party Organization."

Corporate Honors:

2020 China's Top 500 Most Valuable Brands;
Top 500 Listed Companies by Market Value in China;
National Demonstration Base for Industrialization of Achievements from the National High-Tech R&D Program;
International Science and Technology Cooperation Center of the Ministry of Science and Technology;
Top 10 Chinese Ethnic Medicine Brand Enterprises;
Top 50 SME (Small and Medium Enterprise) Board Listed Companies in China;
Top 10 Brands of Traditional Chinese Medicine Products in China;
Top 20 Listed Pharmaceutical Companies in China;

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Yiling Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 深交所

Yiling Pharmaceutical How Fast Is Hiring Growing? (804 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 39%
  • 2024: Up 21%
  • 2023: Up 48%
  • 2022: Down 51%
Yiling Pharmaceutical Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Yiling Pharmaceutical Campus Recruitment & Advanced Degree Talent Demand
Graduates 32 Interns 2 Master's 86 Doctorate 13
No.4
Company Recruitment Ranking in Shijiazhuang City 򀀩
No.148
Recruitment Growth Ranking in Shijiazhuang City 򀀩
No.1
Graduate Talent Ranking in Shijiazhuang City 򀀩
No.4
Intern Talent Ranking in Shijiazhuang City 򀀩
Note: How fast is hiring at Shijiazhuang Yiling Pharmaceutical Co., Ltd. growing? Yiling Pharmaceutical2026: 2949 openings (up 53%), 2025: 1928 openings (up 39%), 2024: 1386 openings (up 21%), 2023: 1149 openings (up 48%), 2022: 776 openings (down 51%), 2021: 1592 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Yiling Pharmaceutical Doctoral Degree Job Demand Analysis

(More)
+156%
Growth Rate
2026 vs 2025
  • 2025: Down 18%
  • 2024: Down 45%
  • 2023: Up 67%
  • 2022: Flat 0%-
Yiling Pharmaceutical Doctoral Hiring by Year: 2026 — 14 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
No.8
Doctoral Demand Ranking in Shijiazhuang City 򀀩
¥20-50K and above
Doctoral Salary 򀀩
How fast is doctoral hiring at Shijiazhuang Yiling Pharmaceutical Co., Ltd. growing? Yiling PharmaceuticalDoctorate recruitment over the years: 2026: 23 openings (up 156%), 2025: 9 openings (down 18%), 2024: 11 openings (down 45%), 2023: 20 openings (up 67%), 2022: 12 openings (flat), 2021: 12 openings. Yiling Pharmaceutical doctorate talent ranking in Shijiazhuang: #8, Yiling Pharmaceutical doctorate salary mostly around 20-50K and above.

Yiling Pharmaceutical R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shijiazhuang Yiling Pharmaceutical Co., Ltd.? Based on an analysis of Yiling Pharmaceutical's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 24.3%, "Computer/Network/Technology": 5.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 3.7%, "Other (R&D and Technical)": 2.9%, "Scientific Research": 2.2%, "Mechanical/Instrumentation": 0.4%. For reference only.

Yiling Pharmaceutical — What Are the Salaries Like? (2617 records)

Manage
Yiling Pharmaceutical Salary Overview
salary range: 4.5K - 50K, 74.2% of roles pay ¥6-15K
Note: salary statistics are based on 2617 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shijiazhuang Yiling Pharmaceutical Co., Ltd.?Yiling Pharmaceutical74.2% of positions earn 6-15K, Fresh graduate salary: ¥6.0K。Shijiazhuang salary ranking top 15,Sales average salary ¥11.2K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Yiling Pharmaceutical — Fortune 500? (More)

Yes, ranked in 中国企业慈善公益500强:

  • NO.180 2023中国企业慈善公益500强 >
  • NO.402 2022中国企业慈善公益500强 >

Yes, ranked in 中国高新技术企业慈善公益500强:

  • NO.25 2023中国高新技术企业慈善公益500强 >
  • NO.85 2022中国高新技术企业慈善公益500强 >

Job Category

  • Sales
    68.5% of total 68.5%
  • Medical & Health/Beauty & Healthcare
    23.5% of total 23.5%
  • Business Management
    16.2% of total 16.2%
  • Marketing/PR/Media
    7.6% of total 7.6%

Education

  • 大专
    60.9% of total 60.9%
  • 本科
    30.1% of total 30.1%
  • 硕士
    4.5% of total 4.5%
  • 不限
    3.4% of total 3.4%

Experience

  • 1-3年
    50.7% of total 50.7%
  • 3-5年
    17.1% of total 17.1%
  • 不限
    15.8% of total 15.8%
  • 5-10年
    15.2% of total 15.2%
View Detailed Analysis

What does Shijiazhuang Yiling Pharmaceutical Co., Ltd. require? Who is Yiling Pharmaceutical hiring? Yiling Pharmaceutical recruitment: Sales占比最多占68.5%,其次是Medical & Health/Beauty & Healthcare占23.5%. What education can get in at Yiling Pharmaceutical? 大专占比最多占60.9%,其次是本科占30.1%. High education required at Yiling Pharmaceutical? 硕士占4.5%,博士占0.8%. Work experience required at Yiling Pharmaceutical? 1-3年占比最多占50.7%,其次是3-5年占17.1%. Where are the job locations at Yiling Pharmaceutical? 石家庄占比最多占21.4%,其次是北京占8.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 167,070.5376万(元)
Legal Representative: 吴相君
Date Established:
Credit Code: 9113000023565800XC
Registered Address: 石家庄市高新技术开发区天山大街238号

Partners & Suppliers

为以岭药业的连花清瘟等产品提供临床试验服务 Source
供应商 制药企业
采购药品:连花清瘟胶囊等 Source
合作客户 药品生产
华润河北医药为以岭药业提供药品物流配送服务。 Source
合作客户 药品生产/供应商
国药控股黑龙江有限公司向以岭药业采购连花清瘟等 Source
合作客户 医药制造-中药
冀德医药作为以岭药业在河北省的主要商业配送商,采购连花清瘟等中成药 Source
合作客户 医药制造

People who follow Yiling Pharmaceutical also follow

Yiling Pharmaceutical Competitors (Similar Companies)

“One of the leading enterprises in the pharmaceutical industry”
“National Leading Enterprise in Agricultural Industrialization”
卫生材料 医药 医药工业 原料药
“Leading modern traditional Chinese medicine, advancing the health indu”
“Research, development, and production of anti-tumor and surgical medic”
“Overall solution provider for smart power solutions”
工程设计 施工总承包 钢结构工程 机电安装
“A renowned enterprise in China's liver disease and anti-tumor fields”
“To develop high-quality biologics that are accessible and affordable f”
“Technological innovation and commercial application of pharmaceutical ”
制药/药业 药物研发 医药中间体 原料药
光通信 光通信技术 卫星导航/GPS 微波
“Committed to righteous success, dedicated to creating value for societ”
“New energy vehicle manufacturer”
电子厂/电子 光电子器件 光电 电子系统

Discover Great Companies, Discover Great Clients

石家庄公司名录 石家庄“Development Zone”公司名录 石家庄“制药/药业”公司名录 石家庄“医药”公司名录 石家庄“生物医药”公司名录 石家庄“药物研发”公司名录 石家庄“生物科技/生物工程”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates